The pathophysiology remains the same, and as a result, clinicians need to remain vigilant for this rare condition in those patients without diabetes mellitus but who continue to take SGLT2 inhibitors peri‐operatively. The gene discussed is SLC5A2; the disease is diabetes mellitus.